| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/04/2013 | CN103271971A Preparation for treating cancer pain |
| 09/04/2013 | CN103271960A Preparation method of ginseng cream richly containing scare ginsenosides Rg3 and Rh2 |
| 09/04/2013 | CN103271955A Brucea javanica oil emulsion composition |
| 09/04/2013 | CN103271947A Novel antitumor application of maggot |
| 09/04/2013 | CN103271941A Novel application of zinc chloride serving as medicine for curing human brain glioma |
| 09/04/2013 | CN103271929A Use of notoginsenoside compound in preparation of drug for treating cancer |
| 09/04/2013 | CN103271923A Medical application of benzothiazine derivative |
| 09/04/2013 | CN103271922A Agent for enhancing anti-tumor effect comprising oxaliplatin liposome preparation, and anti-tumor agent comprising the liposome preparation |
| 09/04/2013 | CN103271919A Application of Myriberine A in preparing drug for treating rectal cancer |
| 09/04/2013 | CN103271918A Application of Myriberine A in preparing drug for treating endometrial cancer |
| 09/04/2013 | CN103271916A Applications of Myriberine A in preparing drugs for treating prostate cancer |
| 09/04/2013 | CN103271914A Applications of Myriberine A in preparing drugs for treating gastric cancer |
| 09/04/2013 | CN103271909A Human breast cancer therapeutic drug taking electric pressure controlled proton channel Hv1 as target spot |
| 09/04/2013 | CN103271906A Use of spiro-oxindole compounds as therapeutic agents |
| 09/04/2013 | CN103271904A Nitric oxide donor endothelin receptor antagonist as well as preparation method and application thereof |
| 09/04/2013 | CN103271902A Slightly-soluble medicine solid dispersion and preparation method thereof |
| 09/04/2013 | CN103271901A Application of dihydromyricetin (DHM) in preparation of anti-hepatoma medicines |
| 09/04/2013 | CN103271898A Application of dencichine to preparation of medicament for treating thrombocytopenia |
| 09/04/2013 | CN103271897A Applications of mesna in preparation of anti-angiogenesis drugs |
| 09/04/2013 | CN103271893A Preparation method for lycopene microcapsule |
| 09/04/2013 | CN103271874A Paclitaxel-encapsulated PEG-PLGA-PEG (Polyethylene Glycol-Polylactic-Co-Glycolic Acid-Polyethylene Glycol) nanoparticle and preparation method thereof |
| 09/04/2013 | CN103271871A Recombinant human interferon injection and preparation method thereof |
| 09/04/2013 | CN103271870A Carrier delivery system with pluronic trigger release delivery function |
| 09/04/2013 | CN102861107B DC-CIK (dendritic cells-cytokine-induced killers) cell treatment composition |
| 09/04/2013 | CN102824352B Application of disaccharide compound in preparing anti-tumor medicine |
| 09/04/2013 | CN102824351B Application of disaccharide compound in preparation of antiviral drug |
| 09/04/2013 | CN102813930B Preparation method of magnetically targeted localization magnetic drug carrier |
| 09/04/2013 | CN102670501B Orally taken vitamin K1 lipid emulsion |
| 09/04/2013 | CN102657599B Method for preparing bioactive injectable hydrogel materials for oncotherapy |
| 09/04/2013 | CN102649841B Polyethylene glycol-modified phospholipid derivative taking anilino-quinazoline as targeting ligand and preparation method thereof |
| 09/04/2013 | CN102633899B Selenized microbial exopolysaccharide, and preparation method and uses thereof |
| 09/04/2013 | CN102617734B Antibody Dab-2 against FGF-2 and application thereof |
| 09/04/2013 | CN102600080B Enzymatic type cleavable PEGylation ( polyethylene glycol) lipid material |
| 09/04/2013 | CN102579999B Medicine for treating carcinous fever and preparation method thereof |
| 09/04/2013 | CN102579828B Orally-taken traditional Chinese medical capsule for treatment of breast cancer |
| 09/04/2013 | CN102579468B Application of 4-1H-1,2,3-triazole-beta-lactam derivative |
| 09/04/2013 | CN102552930B Water-soluble paclitaxel derivative with cell targeting effect and preparation thereof |
| 09/04/2013 | CN102526447B Manufacturing method of external medicine for treating low rectal cancer |
| 09/04/2013 | CN102516164B 1,2-diaryl-5-substituted pyridinium compound, and preparation method and application thereof |
| 09/04/2013 | CN102503908B Vitamin A acid derivative, preparation method thereof, medicine composition thereof and application thereof to preparation anti-tumor medicine |
| 09/04/2013 | CN102463102B Surface-bonded baicalin magnetic nano-particle, and preparation method and application thereof |
| 09/04/2013 | CN102406874B Chinese medicine composition for treating pituitary tumor and application of Chinese medicine composition |
| 09/04/2013 | CN102381951B Cyclohexanone-contained mono-carbonyl analogues of curcumin and usage thereof |
| 09/04/2013 | CN102295562B Antineoplastic compound, its preparation method and applications |
| 09/04/2013 | CN102274279B Juglans mandshurica bark extract and application thereof in preparing anticancer drugs |
| 09/04/2013 | CN102225913B Rheinic acid derivatives and treatment application thereof |
| 09/04/2013 | CN101981037B Pyrazolopyrimidine PI3K inhibitor compounds and methods of use |
| 09/04/2013 | CN101918405B 13a-(s) desoxytylophorinine derivatives, preparation method, pharmaceutical compositon and use thereof |
| 09/04/2013 | CN101918035B Cancer cell death inducer having activity of potentiating anti-cancer agent in cancer having resistance against the anti-cancer agent |
| 09/04/2013 | CN101837003B Formulation of a mixture of free-B-ring flavonoids and flavans as a therapeutic agent |
| 09/04/2013 | CN101796055B Inhibitors of VEGF receptor and HGF receptor signaling |
| 09/04/2013 | CN101269214B EG-VEGF nucleotide and using method |
| 09/04/2013 | CN101265274B Pyrimidinthiazolamine derivatives, and preparation method, medicament composition and use thereof |
| 09/04/2013 | CN101245318B Artificial cultivation method of Basidiomycetes and uses thereof |
| 09/03/2013 | US8524900 Fused heterocyclic derivatives and methods of use |
| 09/03/2013 | US8524720 Substituted N-(pyrazol-5-yl)-pyrrolo[3,2-D]pyrimidin-4-amine useful as protein kinase inhibitors |
| 09/03/2013 | US8524711 Amino-derivatives as novel inhibitors of histone deacetylase |
| 09/03/2013 | US8524702 Substituted benzoazepines as toll-like receptor modulators |
| 09/03/2013 | US8524694 Aminoalkylsterol compounds with antitumoral and neuroprotective activity |
| 09/03/2013 | US8524672 Method for inhibiting BAFF-R activity |
| 09/03/2013 | US8524669 MUC-1 cytoplasmic domain peptides as inhibitors of cancer |
| 09/03/2013 | US8524666 Methods of using vimentin to inhibit angiogenesis and endothelial cell proliferation |
| 09/03/2013 | US8524460 PSCA: prostate stem cell antigen and uses thereof |
| 09/03/2013 | US8524279 Atomizing nozzles include a liquid nozzle adapted to disperse a supply of liquid and a gas nozzle adapted to disperse a supply of gas; spray drying at a commercial plant scale. |
| 09/03/2013 | US8524248 Methods to diagnose and immunize against the virus causing human Merkel cell carcinoma |
| 09/03/2013 | US8524232 Methods of treatment using taci-immunoglobulin fusion proteins |
| 09/03/2013 | US8524193 Non-invasive diagnostic imaging technology for mitochondria using radiolabeled lipophilic salts |
| 09/03/2013 | CA2736921C Tumour-associated peptides that bind to mhc molecules |
| 09/03/2013 | CA2707767C Biologically active peptides |
| 09/03/2013 | CA2707691C Sphingomyelin containing preparation |
| 09/03/2013 | CA2630738C Immunostimulatory oligoribonucleotides |
| 09/03/2013 | CA2612292C Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use |
| 09/03/2013 | CA2609441C 3-aminocarbazole compounds, pharmaceutical composition containing the same and method for the preparation thereof |
| 09/03/2013 | CA2608814C Combination of pyrimidylaminobenzamide compounds and imatinib for treating or preventing proliferative diseases |
| 09/03/2013 | CA2598993C Tetrahydroindolone and tetrahydroindazolone derivatives |
| 09/03/2013 | CA2596754C Crystalline 1h-imidazo[4,5-b]pyridin-5-amine,7-[5-[(cyclohexylmethylamino)-methyl]-1h-indol-2-yl]-2-methyl, sulfate (1:1), trihydrate and its uses for the treatment of inflammatory, autoimmune and proliferative diseases and disorders |
| 09/03/2013 | CA2561696C Novel modified galectin 9 proteins and use thereof |
| 09/03/2013 | CA2548662C Maleate salts of a quinazoline derivative useful as an antiangiogenic agent |
| 09/03/2013 | CA2504963C Conjugates of tnf and a ligand of cd13 receptor in combination with interferon-gamma for treating cancer |
| 09/03/2013 | CA2478294C Gntiii (udp-n-acetylglucosamine:beta-d mannoside beta (1,4)-n-acetylglucosaminyltransferase iii) expression in plants |
| 09/03/2013 | CA2241564C Wsx receptor and ligands |
| 09/01/2013 | CA2807712A1 Methods for treating cancer |
| 08/29/2013 | WO2013126809A1 Prediction of responsiveness to treatment with immunomodulatory therapeutics and method of monitoring abscopal effects during such treatment |
| 08/29/2013 | WO2013126797A1 Cholecystokinin b receptor targeting for imaging and therapy |
| 08/29/2013 | WO2013126776A1 Nanostructures for treating cancers and other conditions |
| 08/29/2013 | WO2013126730A1 Derivatives of avicin d and methods of making and using thereof |
| 08/29/2013 | WO2013126703A1 Reversibly crosslinked helical hydrogen bond surrogate macrocycles |
| 08/29/2013 | WO2013126664A1 Identification of nsc23925 isomers to reverse multidrug resistance in human cancers |
| 08/29/2013 | WO2013126656A1 Pyridopyrimidinone inhibitors of kinases |
| 08/29/2013 | WO2013126636A1 Methods for treating non- small cell lung cancer using tor kinase inhibitor combination therapy |
| 08/29/2013 | WO2013126605A1 EXPRESSION CONSTRUCT FOR A LIN28-RESISTANT Let-7 PRECURSOR MICRORNA |
| 08/29/2013 | WO2013126539A1 Treatment of cancer |
| 08/29/2013 | WO2013126402A1 Composition and methods for treating melanoma |
| 08/29/2013 | WO2013126368A1 Methods, assays, and systems relating to sakt |
| 08/29/2013 | WO2013126146A2 Methods and compositions for enhancing sensitivity of cytotoxic drugs with timely combinatorial therapy with carboxyamidotriazole orotate |
| 08/29/2013 | WO2013124826A1 Oxazolidin- 2 -one compounds and uses thereof as pi3ks inhibitors |
| 08/29/2013 | WO2013124436A1 Synthetic anti-microbial peptides with a minority of cationic and a majority hydrophobic side chains |
| 08/29/2013 | WO2013124419A1 Her3 inhibitor for modulating radiosensitivity |
| 08/29/2013 | WO2013124316A1 Substituted benzothienyl-pyrrolotriazines and uses thereof |
| 08/29/2013 | WO2013124169A1 Use of 1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors |